n-acetylneuraminic acid has been researched along with HIV Coinfection in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Mohsen, M; George, AF; Giron, L; Ma, T; McGregor, M; Roan, NR; Xie, G | 1 |
| Andrabi, R; Briney, B; Burton, DR; Liang, CH; Nawazi, SK; Shivatare, SS; Su, CY; Voss, JE; Wong, CH; Wu, CY | 1 |
| Bakari, M; Brickley, EB; Connor, RI; Hendricks, KM; Housman, ML; Lukmanji, Z; Lyimo, MA; Magohe, AK; Maro, I; Matee, M; Mchaki, B; Pallangyo, K; Von Reyn, CF; Zain-Ul-Abideen, M | 1 |
| Alsalmi, W; Alving, CR; Ehrenberg, PK; Gao, G; Jobe, O; Kim, J; Kim, JH; Michael, NL; Peachman, KK; Rao, M; Rao, VB; Thomas, R; Tovanabutra, S; Trinh, HV | 1 |
| Clayton, R; Hardman, J; LaBranche, CC; McReynolds, KD | 1 |
| Auberger, P; Baum, LG; Fukuda, M; Fuzibet, JG; Giordanengo, V; Hiraoka, N; Lantéri, M; Lefebvre, JC | 1 |
| Fujita, S; Mastico, R; Suda, I; Terada, M | 1 |
| Cottalorda, J; Desroys du Roure, L; Doglio, A; Fuzibet, JG; Giordanengo, V; Lefebvre, JC; Limouse, M; Passeron, A | 1 |
| Leoni, LM; Losa, GA | 1 |
| Bannwarth, S; Blaive, B; Giordanengo, V; Lefebvre, JC; Perrin, C | 1 |
| James, JS | 1 |
1 trial(s) available for n-acetylneuraminic acid and HIV Coinfection
| Article | Year |
|---|---|
Sialic acid levels in breast milk from HIV-positive Tanzanian women and impact of maternal diet.
Topics: Adult; Body Mass Index; CD4 Lymphocyte Count; Diet; Female; HIV Infections; Humans; Infant; Infant, Newborn; Male; Milk, Human; N-Acetylneuraminic Acid; Tanzania | 2019 |
10 other study(ies) available for n-acetylneuraminic acid and HIV Coinfection
| Article | Year |
|---|---|
Single-cell glycomics analysis by CyTOF-Lec reveals glycan features defining cells differentially susceptible to HIV.
Topics: CD4-Positive T-Lymphocytes; Disease Susceptibility; Fucose; Glycomics; HIV Infections; HIV-1; Humans; N-Acetylneuraminic Acid; Polysaccharides | 2022 |
Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development.
Topics: Amino Acid Sequence; Antibodies, Neutralizing; Antibody Affinity; Antibody Formation; Binding Sites; Epitopes; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Immunoglobulin Heavy Chains; Models, Molecular; N-Acetylneuraminic Acid; Neutralization Tests; Peptide Fragments; Phylogeny; Polysaccharides; Protein Binding; Protein Conformation; Protein Multimerization | 2017 |
Effect of cytokines on Siglec-1 and HIV-1 entry in monocyte-derived macrophages: the importance of HIV-1 envelope V1V2 region.
Topics: Capsid Proteins; Cytokines; Granulocyte-Macrophage Colony-Stimulating Factor; HIV Infections; HIV-1; Humans; Lactose; Macrophage Colony-Stimulating Factor; Macrophages; Monocytes; N-Acetylneuraminic Acid; Protein Multimerization; Receptors, Virus; Sialic Acid Binding Ig-like Lectin 1; Sialic Acids; Viral Envelope Proteins; Virus Internalization; Virus Replication | 2016 |
Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compounds.
Topics: Anti-HIV Agents; Dendrimers; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; N-Acetylneuraminic Acid | 2011 |
Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death.
Topics: Amino Sugars; Antigens, CD; Apoptosis; Cell Death; Cell Line, Tumor; Cell Survival; Dithiothreitol; Galectin 1; Glycoproteins; Glycosylation; HIV Infections; Humans; Leukocyte Common Antigens; Leukosialin; N-Acetylneuraminic Acid; Oligosaccharides; Polysaccharides; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Sialoglycoproteins; T-Lymphocytes | 2003 |
Polysulfated sialic acid derivatives as anti-human immunodeficiency virus.
Topics: Alkylation; Animals; Anti-HIV Agents; Anticoagulants; Dextran Sulfate; Dose-Response Relationship, Drug; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Lethal Dose 50; Lipids; Macaca fascicularis; Mice; Mice, Inbred NOD; Mice, SCID; Models, Animal; N-Acetylneuraminic Acid; Sialic Acids; T-Lymphocytes; U937 Cells; Virus Replication; Zidovudine | 2005 |
Autoantibodies directed against CD43 molecules with an altered glycosylation status on human immunodeficiency virus type 1 (HIV-1)-infected CEM cells are found in all HIV-1+ individuals.
Topics: Acquired Immunodeficiency Syndrome; Antigens, CD; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; Cell Line; Cross Reactions; Glycosylation; Hepatitis B; HIV Infections; HIV-1; Humans; Immunoglobulin G; Immunoglobulin M; Leukosialin; Lupus Erythematosus, Systemic; Molecular Weight; N-Acetylneuraminic Acid; Sialic Acids; Sialoglycoproteins; T-Lymphocytes | 1995 |
Changes in membrane enzymes and glycosphingolipids in lymphocytes from HIV-1--infected and noninfected intravenous drug users.
Topics: 5'-Nucleotidase; Adolescent; Adult; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Membrane; Endopeptidases; Enzymes; Female; Gangliosides; Glutathione Transferase; Glycosphingolipids; HIV Infections; HIV Seropositivity; HIV-1; Humans; Immunophenotyping; Lymphocytes; Male; Middle Aged; N-Acetylneuraminic Acid; Neprilysin; Sialic Acids; Substance Abuse, Intravenous; Type C Phospholipases | 1996 |
Altered sialylation of alveolar macrophages in HIV-1-infected individuals.
Topics: Adult; HIV Infections; HIV-1; Humans; Lectins; Macrophages, Alveolar; Middle Aged; N-Acetylneuraminic Acid; Polysaccharides | 1997 |
Flu epidemic: shots, new treatments available.
Topics: Acetamides; Antiviral Agents; HIV Infections; Humans; Influenza Vaccines; Influenza, Human; N-Acetylneuraminic Acid; United States | 2000 |